Everolimus Exposure and Early Metabolic Response as Predictors of Treatment Outcomes in Breast Cancer Patients Treated with Everolimus and Exemestane

Annelieke E.C.A.B. Willemsen, Lioe Fee de Geus-Oei, Maaike de Boer, Jolien Tol, Yvonne Kamm, Paul C. de Jong, Marianne A. Jonker, Allert H. Vos, Willem Grootjans, Johannes W.B. de Groot, Sasja F. Mulder, Erik H.J.G. Aarntzen, Winald R. Gerritsen, Carla M.L. van Herpen, Nielka P. van Erp*

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

7 Citations (Scopus)
6 Downloads (Pure)

Fingerprint

Dive into the research topics of 'Everolimus Exposure and Early Metabolic Response as Predictors of Treatment Outcomes in Breast Cancer Patients Treated with Everolimus and Exemestane'. Together they form a unique fingerprint.

Medicine & Life Sciences